Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
AIM ImmunoTech Inc. amended loan of $1,682,676.16 with Streeterville Capital, LLC maturing June 30, 2027.
- Instrument
- loan
- Principal
- $1,682,676.16
- Counterparty
- Streeterville Capital, LLC
- Maturity
- June 30, 2027
- Event
- amendment
Exact text from the filing
as a representation and warranty of the Company that, as of the date of the Amendment, the outstanding balance of the Note, following the application of the Extension Fee, was $1,682,676.16. The foregoing is only a summary of the material terms of the Amendment and does not purport to be a complete description of the rights and obligations of the parties thereunder.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
AIM ImmunoTech Inc. amended Amendment #2 to Promissory Note with Streeterville Capital, LLC valued at extension fee in the amount of $10,000.00 (effective 2026-05-18).
- Action
- amendment
- Agreement
- credit facility
- Counterparty
- Streeterville Capital, LLC
- Value
- extension fee in the amount of $10,000.00
- Effective
- 2026-05-18
Exact text from the filing
On May 18, 2026, the Company and the Lender entered into Amendment #2 to Promissory Note (the “Amendment”), which amended the Note and further extended the maturity date of the Note until June 30, 2027. Pursuant to the Amendment, the Company agreed to pay the Lender an extension fee in the amount of $10,000.00 (the “Extension Fee”), which Extension Fee was added to the outstanding balance of the Note.
View on SEC.gov